SEC Form 4 · accession 0000899243-19-003183
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary Charles Robb
Officer — Chief Financial Officer
Period of report
Dec 26, 2018
Accepted (ET)
Feb 11, 2019 · 5:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 26, 2018 | G | 1,167 | $0.00 | A | 2,735 | I | Custodial account for child |
| Common StockF1 | Dec 26, 2018 | G | 1,167 | $0.00 | A | 2,735 | I | Custodial account for child |
| Common StockF1 | Dec 26, 2018 | G | 1,167 | $0.00 | A | 2,735 | I | Custodial account for child |
| Common Stock | Dec 26, 2018 | G | 1,167 | $0.00 | A | 8,025 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.